Actively Recruiting
Protein Supplementation After ACL Surgery
Led by The Methodist Hospital Research Institute · Updated on 2025-05-06
102
Participants Needed
1
Research Sites
197 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to assess the longitudinal post-operative care effects of protein supplementation on muscle atrophy in the post-operative period following ACL reconstruction. The main outcome will be muscle size/mass as measured using dual energy x-ray absorptiometry (DEXA) scanning. The primary objective is to assess for any beneficial impact of protein supplementation, with implications of standardizing a recommended protocol for protein supplementation after ACL reconstruction. Secondary outcomes will be to evaluate the survey data from the KOOS JR and Tampa Scale surveys, as well as functional measures recorded during physical therapy.
CONDITIONS
Official Title
Protein Supplementation After ACL Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 16 to 40 undergoing primary ACL reconstruction for an acute ACL tear
- Patients treated by the principal investigator or sub-investigators
You will not qualify if you...
- History of meniscectomy or meniscus repair
- Obesity with BMI over 35
- Diabetes
- Cardiovascular, renal, liver, or pulmonary disease
- Active infections
- Current cancer or cancer treated within past 2 years, or coagulation disorders
- Rapid weight change within the past year
- Physically unable to participate in the intervention
- Use of prescribed or over-the-counter ergogenic aids or banned compounds within 1 month prior to participation
- Age less than 16 years or over 40 years
- Vegan patients
- Pregnancy (negative urine pregnancy test required prior to surgery)
- Known kidney, gastrointestinal, or liver disorders
- Use of medications affecting protein metabolism, including hormone replacement therapy for hypothyroidism, hypogonadism, growth hormone treatments, or insulin for diabetes
- Current use of protein supplements, amino acid supplements, or ergogenic aids
- Not participating in rehabilitation through Houston Methodist
- Diagnosed protein intolerance or digestive issues related to protein consumption
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Houston Methodist
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
H
Haley Goble, MHA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here